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Abstract
Background: Lassa fever is highly contagious and commonly results in death. It is therefore necessary to diagnose
and report any suspected case of Lassa fever to facilitate preventive strategies. This study assessed the
preparedness of physicians in the diagnosis and reporting of Lassa fever.
Methods: The study design was descriptive cross-sectional. The consenting medical doctors completed a
self-administered questionnaire on the diagnosis and reporting of Lassa fever. Descriptive and inferential statistics
were used in data analyses.
Results: One hundred seventy-five physicians participated in the study. The mean age was 41.5 ± 10.9 years
(range, 24–75 years). Most of the physicians were male (78.9%) and had practiced medicine ≥ 20 years (51.5%). Most
of the physicians had a good knowledge regarding the diagnosis and reporting of Lassa fever; however, none of
the physicians had ever diagnosed or reported a suspected case. Predictors of good knowledge include male sex,
not practicing at a secondary health care level and post graduation year more than 20 years.
Conclusion: There is disparity in knowledge and practices of physicians regarding the diagnosis and reporting of
Lassa fever. Thus, it is necessary to improve the knowledge and practices of physicians regarding the diagnosis and
reporting of Lassa fever.
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Background
Lassa fever is a viral haemorrhagic fever caused by a
rodent-borne arenavirus that is endemic to West Africa
[1-3]. Arenaviruses are emerging in the African contin-
ent and can cause haemorrhagic fevers with case fatal-
ities between 10% and 20% [4,5]. These viruses are
mainly transmitted through contact with the excreta of
the natural host (rodents of the family Muridae) [6-8].
The Old World arenavirus, Lassa virus, causes up to
300,000 cases of Lassa fever annually in West Africa
[9-11]. In the 1970s the rodent host of Lassa virus was
classified as Mastomys natalensis. Other rodent hosts,
such as M. erythroleucus, and the Rattus and Mus genera,
have been suggested [12-14]. Health care workers are
predominantly infected and likely to die from Lassa
fever in the central and southern parts of Nigeria, most
often due to poor medical practices, late diagnosis, and
treatment [10,15]. The establishment of diagnostic facil-
ities that can provide rapid molecular testing at referral
centers in the disease-endemic zones has been suggested
as a partial solution to this problem. This testing would
facilitate appropriate case and contact management, in-
cluding early treatment and post-exposure prophylaxis
with Ribavirin, and eventually raise awareness that Lassa
fever should be considered in every severe febrile illness in
these regions of Nigeria and West Africa [14,16].
Although no previous cases of Lassa fever has been
reported in the State of Osun in Nigeria, outbreaks of the
disease were reported in several states of Nigeria including
nearby Edo state.
In the first quarter of 2012, 623 suspected cases, includ-
ing 70 deaths were recorded from 19 of the 36 States of
Nigeria. Laboratory analysis undertaken at the Irrua
Specialist Teaching Hospital, Irrua Edo State, Nigeria
confirmed the presence of Lassa virus infection in 108* Correspondence: sanuolowookere@yahoo.com1Department of Community Health, Faculty of Clinical Sciences, College of
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patients. Three doctors and four nurses were among
the fatalities [17].
Since medical doctors are the first point of contact in
diagnosing and reporting cases of Lassa fever, it is impera-
tive to conduct baseline studies to assess the diagnostic
knowledge and reporting of Lassa fever among physicians
in Nigeria, hence the need for this study.
This study determined the preparedness of physicians
in the diagnosis and reporting of Lassa fever.
Methods
Study setting
Osun state is one of 36 states in Nigeria, and is located in
the southwestern part of Nigeria. Osun state is bounded on
the north by Kwara state, on the east by Ekiti and Ondo
states, on the south by Ogun state, and on the west by Oyo
state. Osun state has 30 local government areas with several
maternity centres, comprehensive health centres, and state
hospitals spread across the state. Also, LAUTECH Teaching
Hospital, Osogbo and Obafemi Awolowo University
Teaching Hospital Complex, Ile-Ife are situated in Osun
state. As at the time this study was conducted, about 600
medical doctors practice medicine in Osun state.
Study design
This was a descriptive cross-sectional study conducted in
the month of June, 2013. All physicians attending a Nigerian
Medical Association (NMA)-organized Continuing Medical
Education programme at the NMA house in Osogbo, which
is a requirement for annual licensure, were approached, after
taken their consent.
Data collection
A validated (face validity) semi-structured, self-administered
questionnaire was used to obtain data on the respondents
sociodemographic characteristics, knowledge, diagnosis,
management and reporting of Lassa fever.
Data analysis
The data obtained were entered into SPSS version 16
and analyzed as frequencies for categorical variables, and
mean and standard deviation for continuous variables.
Knowledge score was computed for a 19-item question
on general knowledge of Lassa fever. Each item was
assigned ‘+1’ for correct knowledge and ‘0’ for incorrect
knowledge. The knowledge score was graded as good or
appropriate (if respondent scored ≥ 10 points), and not
good or not appropriate (if score was < 10 points).
Knowledge score was also computed for a 10-item question
on Lassa fever management and reporting. Each item
was assigned ‘+1’ for correct knowledge and ‘0’ for
incorrect knowledge. The score was classified into good or
appropriate (if respondent scored > 5 points) and not good
or not appropriate (≤5 points). Bivariate chi-square test
and multivariate logistic analyses were performed on
respondent’s characteristics and general knowledge on
Lassa fever, as well as knowledge on management and
reporting. Variables in the bivariate test with p-value of <0.2
were included in the multi-variate model. A p value <0.05
was accepted as significant.
Ethical clearance
Permission to conduct the study was sought from the
Osun state branch of the Nigerian Medical Association,
while verbal consent was obtained from every medical doc-
tor approached to participate in the study. Permission to
conduct the study was granted by the State Hospital Ethics
and Research Committee (protocol no: SHO/ERC/13/007).
The data collected was entered and kept in a password-
protected computer.
Results
Characteristics of respondents
Out of 192 physicians, 5 declined participation while 9
did not return their questionnaire. Three questionnaires
were excluded from analysis because of non-completeness.
One hundred seventy-five questionnaires with completed
data were analysed. The mean age of the study participants
was 41.5 ± 10.9 years, majority (78.9%) of them were males,
83.4% were married, while a larger proportion (92.6%) were
of Yoruba tribe. More than half (51.5%) of the study par-
ticipants had a post University graduation of more than
20 years to the time of the data collection, 47.3% ranged
between 10 to 20 years and only 1.2% had graduated less
than 10 years ago (Table 1). About 44.9% of the partici-
pants had more than five years of post residency training.
The mean number of years of participant’s clinical practice
in primary, secondary and tertiary health care was 6.3, 8.8,
and 6.5 years respectively.
About 18.9% of the respondents were consultants, only
16.6% were medical officers, and the rest are shown in
Table 1. Some physicians worked in primary care such as
General out-patient department (GOPD) (22.4%), Family
medicine (5.6%), Community Health (8.8%), Health centre
(7.2%) and private practice (2.4%).
Lassa fever knowledge
Figure 1 shows that more than half (62%) of the respondents
had good general knowledge on Lassa fever. As shown in
Table 2, majority (93.1%) of the respondents knew that Lassa
fever is a viral infection, 57.1% agreed that the incubation
period ranges from 1 – 3 weeks, and 85.2% agreed the infec-
tion can be characterized by fever > 38°C. Majority (82.9%)
of the respondents reported that cases can not be confirmed
without laboratory diagnosis, and 98.2% of them disagreed
to ‘pediatrics clients being excluded from diagnoses’. Only
34.8% of the respondents agreed that aerosol transmission
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of the infection is possible, while 43.0% reported semen of
case being capable of transmitting infection.
Knowledge on Lassa fever treatment
Table 3 shows the response of the participants to know-
ledge of Lassa fever treatment. Ribavirin was reported by
80.6% of the respondents as the drug used for treatment
of Lassa fever, other drugs listed were Corticosteroid
(5.6%), Ranitidine (5.6%), and antiviral drug (8.2%). Ma-
jority (61.2%) of the respondents reported absence of
bleeding to be a good prognostic sign during Lassa fever
treatment.
Knowledge on Lassa fever reporting
Few (19.4%) of the respondents agreed that a critical
number of cases must be observed before reporting,
Table 1 Respondent’s characteristics
Variable Frequency (n) Percentage (%)
Age:
20–24 years 2 1.4
25–29 years 18 12.2
30–34 years 26 17.6
35–39 years 30 20.3
≥ 40 years 72 48.6
Gender:
Male 138 78.9
Female 37 21.1
Ethnicity:
Yoruba 162 92.6
Igbo 8 4.6
Other 5 2.9
Year of graduation:
More than 20 years 85 51.5
10–20 years 78 47.3
Less than 20 years 2 1.2
Years of post residency:
≤ 5 years 27 55.1
> 5 years 22 44.9
Primary clinical practice:
Yes 70 40
No 105 60
Secondary clinical practice:
Yes 111 63.4
No 64 36.6
Tertiary clinical practice:
Yes 99 56.6
No 76 43.4
Designation:
Consultant 33 18.9
Medical officer 29 16.6
Other 22 12.6
Senior medical officer 21 12.0
Registrar 19 10.9
Chief medical officer 20 11.4
Senior registrar 14 8.0
House officer 10 5.7
Principal medical officer 7 4.0
Department:
A & E 3 2.4
Anesthesia 3 2.4
Biochemistry 2 1.6
Dental health 16 12.8
Table 1 Respondent’s characteristics (Continued)
Community health 11 8.8
ENT 2 1.6
Family medicine 7 5.6
GOPD 28 22.4
Health centre 9 7.2
Internal medicine 3 2.4
Anatomy 1 0.8
O & G 6 4.8
Ophthalmology 3 2.4
Oral path/OMS 3 2.4
Orthopaedics 1 0.8
Pediatrics 4 3.2
Private practice 3 2.4
Psychiatry 1 0.8
Radiology 1 0.8
Surgery 17 13.6
Hospital board 1 0.8
Figure 1 Graded score on Lassa fever knowledge.
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Table 2 Lassa fever knowledge
Variable Frequency
(n)
Percentage
(%)
Lassa fever is a viral disease:
Yes 163 93.1
No 5 2.9
Incubation period ranges for 1–3 weeks:
Yes 100 57.1
No 64 36.6
Reservoir – rat:
Yes 169 96.6
No 3 1.7
Transmitted by rat biting:
Yes 34 19.4
No 131 74.9
Cases are characterized by fever >38°C:
Yes 144 85.2
No 25 14.8
Retrosternal pain is a common
symptom:
Yes 66 41.5
No 93 58.5
Bleeding from mucosal surface is a sign:
Yes 142 84.5
No 26 15.5
Vomiting and shock is rarely observed:
Yes 43 25.3
No 127 74.7
Proteinuria is suggestive:
Yes 44 27.2
No 127 72.8
Fever refractory to treat and mucosal
bleeding is a sign:
Yes 134 79.3
No 35 20.7
Absence of profuse mucosal bleeding
exclude diagnosis:
Yes 5 3
No 161 97
Pediatrics clients are excluded
from diagnosis:
Yes 3 1.8
No 164 98.2
Cases can be confirmed without lab
diagnosis:
Yes 28 17.1
No 136 82.9
Table 2 Lassa fever knowledge (Continued)
Aerosol transmission:
Yes 57 34.8
No 107 65.2
Causative organism penetrates
unbroken skin:
Yes 37 22.8
No 125 77.2
Cases cease to be infectious after
acute phase:
Yes 18 11.0
No 146 89.0
Semen of case is capable of transmitting
infection:
Yes 71 43.0
No 94 57.0
Jaundice is a common manifestation:
Yes 103 62.4
No 62 37.6
Bodies of dead cases constitute
potential harm:
Yes 122 73.1
No 45 26.9
Table 3 Treatment agent
Variable Frequency (n) Percentage (%)
Drug used for treatment:
Ribavirin 29 80.6
Corticosteroid 2 5.6
Ranitidine 2 5.6
Antiviral drug 3 8.2
Patients nursed in open wards:
Yes 7 4.5
No 133 84.7
Not sure 17 10.8
Corticosteroids important in
management:
Yes 53 34.2
No 31 20.0
Not sure 71 45.8
Absence of bleeding good
prognostic sign:
Yes 98 61.2
No 16 10.0
Not sure 46 28.8
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while 80.6% did not agree to that. Most (82.5%) of the
participants agreed that suspected cases qualify for
reporting, while 73% agreed that confirmed cases can be
reported. More than half (61.1%) of the respondents re-
ported that it is not true that cases should be reported
weekly for administrative efficiency (Table 4).
Respondent’s characteristics and Lassa fever knowledge
Table 5 shows the association of respondent’s charac-
teristics with knowledge of Lassa fever. A higher pro-
portion (77.3%) of the respondents who were older
than 40 years had an appropriate knowledge on Lassa
fever, compared to 21.9% of those who were younger
than 40 years, although this was not significant (p = 1.000).
Surprisingly, a significantly higher proportion (35.8%)
of the respondents who did not have clinical practice
in a secondary health facility had an appropriate know-
ledge on Lassa fever, compared to 19.8% of those
who were had practiced in a secondary health facility
(p = 0.049).
Predictors of knowledge on Lassa fever
Table 6 shows the result of the multivariable model. Re-
spondents who were not practicing at a secondary health
care level were more likely to have an appropriate know-
ledge on Lassa fever (OR = 0.41, 95% CI = 0.192–0.889).
Association between respondent’s characteristics and
knowledge on management and reporting of Lassa fever
A higher proportion (42.6%) of respondents who were
males were more likely to have a good knowledge on
Table 4 Knowledge on Lassa fever reporting
Variable Frequency (n) Percentage (%)
Critical minimum number of cases
must be observed before reporting:
True 30 19.4
Not true 125 80.6
Suspected case:
True 138 82.5
Not true 28 17.5
Confirmed case:
True 43 27
Not true 116 73
Weekly reporting:
True 58 38.9
Not true 91 61.1
Federal:
True 79 50
Not true 79 50
State:
True 83 52.5
Not true 75 47.5
Local:
True 67 43.8
Not true 86 56.2
Table 5 Association between respondent’s characteristics
and Lassa fever knowledge
Knowledge
Variable Appropriate Not
appropriate
χ2 P-value
Age:
< 40 years 14 (21.9) 50 (78.1)
≥ 40 years 51 (77.3) 15 (22.7) 0.907 1.000
Gender:
Male 31 (25.8) 89 (74.2)
Female 22 (75.9) 7 (24.1) 0.851 1.000
Ethnicity:
Yoruba 34 (24.6) 104 (75.4)
Igbo 3 (37.5) 5 (62.5)
Other 1 (33.3) 2 (66.7) 0.757 0.685
Marital status:
Currently married 34 (26.6) 94 (73.4)
Currently not married 4 (19.0) 17 (81.0) 0.414 0.594
Years of graduation:
More than 20 years 20 (26.7) 55 (73.3)
10–20 years 16 (23.2) 53 (76.8) 0.865 0.471
Less than 10 years
Years of residency:
≤ 5 years 6 (27.3) 16 (72.7)
> 5 years 5 (25.0) 15 (75.0) 0.867 1.000
Primary health care
practice: Yes 13 (20) 52 (80)
No 25 (29.8) 59 (70.2) 0.175 0.190
Secondary health care
practice: Yes 19 (19.8) 77 (80.2)
No 19 (35.8) 34 (64.2) 0.031 0.049
Tertiary health care
practice: Yes 23 (26.7) 63 (73.3)
No 15 (23.8) 48 (76.2) 0.685 0.708
Table 6 Logistic regression for respondent’s
characteristics and Lassa fever knowledge
Variable OR 95% CI P-value
Primary health care practice 0.54 0.245–1.180 0.122
Secondary health care practice 0.41 0.192–0.889 0.024
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Lassa fever management and reporting, compared to fe-
males (34.3%), p = 0.244. Respondents who had more
than 20 years of post graduation from medical school
had a higher (49.4%) level of knowledge on Lassa fever
management and reporting, compared to those who had
less than 20 years of post graduation (33.3%), p = 0.031
(Table 7).
Predictors of knowledge on Lassa fever management and
reporting
In the multi-variate analysis, the only factor that was
significantly predictive of knowledge on Lassa fever
management and reporting was years of graduation.
Table 8 shows that respondents who had post gradu-
ation year more than 20 years were more likely to have
a good knowledge compared to those who had 20 years
or lesser post graduation experience (OR = 0.48, 95%
CI = 0.24–0.94).
Discussion
This study assessed the knowledge, diagnosis, and reporting
of Lassa fever by physicians in Nigeria. Specifically, nearly
all respondents had practiced medicine for > 10 years. Des-
pite this, none of the respondents had managed or reported
a suspected case of Lassa fever. This was probably because
Lassa fever is not one of the differential diagnoses usually
considered when patients with febrile illnesses present for
evaluation. Several studies on Lassa virus detection have re-
ported that misdiagnoses are common among physicians
due to the non-consideration of Lassa fever as a cause of
febrile illness and the non-specific clinical signs and
symptoms of a large proportion of Lassa infections,
combined with the lack of familiarity of physicians with
Lassa fever, suggesting that the infection can easily be
misdiagnosed [18-22].
However, most physicians interviewed had appropriate
knowledge of Lassa fever. Thus, a disconnect between
knowledge and practice as probable cases could have
presented to these physicians that had been misdiag-
nosed leading to progression of the disease as seen in
areas with low reporting of Lassa fever [21-23]. It is
therefore essential that physicians, especially those prac-
ticing in primary care, should be targeted in training on
emerging diseases to increase their index of suspicion
and protect themselves from exposure to this deadly
virus. This training will help every physician, whether
they have ‘good’ or ‘poor’ knowledge regarding the diag-
nosis, management, and reporting of Lassa fever. The
training should emphasize the concept of universal pre-
cautions, which must be observed by every health care
worker while interacting with every patient [24-27].
Although all respondents believe the State Ministry of
Health and their hospital pharmacy should stock Ribavirin,
Table 7 Association between respondent’s characteristics
and knowledge on management and reporting of Lassa
fever
Knowledge
Variable Good Fair χ2 p-value
Age:
< 40 years 29 (40.3) 43 (59.7)
≥ 40 years 30 (44.1) 38 (55.9) 0.211 0.386
Gender:
Male 55 (42.6) 89 (74.2)
Female 12 (34.3) 7 (24.1) 0.794 0.244
Ethnicity:
Yoruba 59 (39.1) 92 (60.9)
Igbo 4 (50.0) 4 (50.0)
Other 4 (80.0) 1 (20.0) 3.646 0.162
Marital status:
Currently married 59 (42.1) 81 (57.9)
Currently not married 4 (33.3) 16 (66.7) 0.658 0.281
Years of graduation:
> 20 years 40 (49.4) 41 (50.6)
≤ 20 years 25 (33.3) 50 (66.7) 4.127 0.031
Years of residency:
≤ 5 years 10 (41.7) 14 (58.3)
> 5 years 7 (31.8) 15 (68.2) 0.478 0.351
Primary health care
practice: Yes 25 (39.1) 39 (60.9)
No 10 (45.5) 12 (54.5) 0.277 0.389
Secondary health care
practice: Yes 45 (42.5) 61 (57.5)
No 2(33.3) 4 (66.7) 0.194 0.503
Tertiary health care
practice: Yes 38 (40.4) 56 (59.6)
No 1 (50.0) 1 (50.0) 0.740 0.650
Table 8 Logistic regression for respondent’s
characteristics and knowledge on Lassa fever
management and reporting
Variable OR 95% CI p-value
Gender: Male 0.86 0.38 – 1.96 0.72
Female 1
Ethnicity:
Yoruba 1
Igbo 0.65 0.15 – 2.77 0.56
Other 0.13 0.01 – 1.28 0.08
Year of graduation:
> 20 years 0.48 0.24 – 0.94 0.032
≤ 20 years 1
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which is used for post-exposure prophylaxis by all contacts
of suspected cases [24,27], none of the physicians could
state categorically that Ribavirin is available at all times in
the hospitals with which they are affiliated. Also, no phys-
ician had the occasion to prescribe the drug previously.
This showed the low-risk perception among these physi-
cians of Lassa fever, implying that more efforts should be
made by an appropriate authority to make Ribavirin avail-
able in all hospitals and equally inform the health care
workers for easy access by contacts of suspected cases.
The limitation of this study was that only physicians
present at the NMA continuous medical education con-
ference were included. Although, we expected that the
programme would require the participation of all doc-
tors, this was not so based on the number who attended.
We recognized that selection bias may have occurred as
those who attended may be different in some character-
istics (which may affect the outcome of the study) from
those who did not attend, limiting the generalization of
our study findings. However, the type of physicians who
see the Lassa fever cases initially are generally primary
care physicians, who work in private and public owned
health care facilities. These practitioners formed about
half (46.4%) of the study participants. Also, the study
was cross-sectional and used a self-administered ques-
tionnaire. However, to the best of our knowledge, this
is the first study to be conducted on the diagnosis and
reporting of Lassa fever in the study area. This there-
fore serves as a baseline study to implement interven-
tions to control possible epidemics of Lassa fever in the
study area.
Conclusion
In conclusion, despite having an appropriate knowledge
about Lassa fever, no suspected case has ever been diag-
nosed or reported by the physician participants. It is ne-
cessary to improve physician knowledge and practice on
Lassa fever through continuous medical education. It is
equally essential to ensure implementation of Lassa fever
diagnostics and surveillance.
Competing interests
The authors declare that they had no competing interests.
Authors’ contributions
SAO and AAF made substantial contributions to conception and design of
the study while all the authors were involved in data collection, analysis and
interpretation. All authors were involved in writing the manuscript and
approved the final copy.
Acknowledgement
The authors wished to thank the executive members of the Osun state
Nigerian Medical Association and physicians that participated in this study.
Author details
1Department of Community Health, Faculty of Clinical Sciences, College of
Health Sciences, Obafemi Awolowo University, Ile-Ife, Osun state, Nigeria.
2Department of Epidemiology and Medical Statistics, University of Ibadan,
Ibadan, Nigeria. 3Department of Maxillofacial Surgery, University of Ibadan,
Ibadan, Nigeria. 4Department of Preventive Medicine, State Specialist
Hospital, Asubiaro, OsogboOsun-State, Nigeria.
Received: 2 January 2014 Accepted: 17 June 2014
Published: 20 June 2014
References
1. Macher AM, Wolfe MS: Historical Lassa fever reports and 30-year clinical
update. Emerg Infect Dis 2006, 12(5):835–837. http://www.ncbi.nlm.nih.gov/
pmc/articles/PMC3374442/. doi: 10.3201/eid1205.050052.
2. Ibekwe T: Lassa fever: the challenge of curtaining a deadly disease.
Pan Afr Med J 2012, 11:55. http://www.panafrican-med-journal.com/content/
article/11/55/full/.
3. Richmond JK, Baglole DJ: assa fever: epidemiology, clinical features, and
social consequences. BMJ 2003, 327(7426):1271–1275. doi: http://dx.doi.
org/10.1136/bmj.327.7426.1271.
4. Lecompte E, Fichet-Calvet E, Daffis S, Koulemou K, Sylla O, Kourouma F,
Dore A, Soropogui B, Aniskin V, Allali B, Kan KS, Lalis A, Koivogui L, Gunther
S, Denys C, Meulen J: Mastomys natalensis and Lassa Fever, West Africa.
Emerg Infect Dis 2006, 12(12):1971–1974. doi: 10.3201/eid1212.060812
DOI:10.3201%2Feid1212.060812#pmc_ext.
5. Kitching A, Addiman S, Cathcart S, Bischop L, Krahé D, Nicholas M, Coakley
J, Lloyd G, Brooks T, Morgan D, Turbitt D: A fatal case of Lassa fever in
London, January 2009. Euro Surveill 2009, 14(6). http://www.
eurosurveillance.org/ViewArticle.aspx?ArticleId=19117.
6. Yun NE, Walker DH: Pathogenesis of Lassa fever. Viruses 2012, 2031–2048:4.
doi: 10.3390/v4102031.
7. Salazar-Bravo J, Ruedas LA, Yates TL: Mammalian reservoirs of
arenaviruses. Curr Top Microbiol Immunol 2002, 262:25–63. http://www.ncbi.
nlm.nih.gov/pubmed/11987807.
8. Lassa Fever Fact Sheet. Centers for Disease Control and Prevention. http://
www.cdc.gov/ncidod/dvrd/spb/mnpages/dispages/Fact_Sheets/
Lassa_Fever_Fact_Sheet.pdf.
9. Safronetz D, Lopez JE, Sogoba N, Traore SF, Raffel SJ, Fischer ER, Ebihara H,
Branco L, Garry RF, Schwan TG, Feldmann H: Detection of Lassa virus, Mali.
Emerg Infect Dis 2010, 16(7):1123–1126. http://wwwnc.cdc.gov/eid/article/
16/7/10-0146_article.
10. Ehichioya DU, Hass M, Ölschläger S, Becker-Ziaja B, Chukwu COO, Coker J,
Nasidi A, Ogugua O, Günther S, Omilabu SA: Lassa Fever, Nigeria, 2005–2008.
Emerg Infect Dis 2010, 16(6):1040–1041. doi: 10.3201/eid1606.100080.
11. Flatz L, Rieger T, Merkler D, Bergthaler A, Regen T, Schedensack M,
Bestmann L, Verschoor A, Kreutzfeldt M, Brück W, Hanisch U-K, Günther S,
Pinschewer DD: T cell-dependence of Lassa fever pathogenesis. PLoS
Pathog 2010, 6:e1000836. doi:10.1371/journal.ppat.1000836.
12. Hensley L, Smith M, Geisbert J, Fritz E, Daddario-DiCaprio K, Larsen T,
Geisbert T: Pathogenesis of Lassa fever in cynomolgus macaques.
Virol J 2011, 8:205. http://www.virologyj.com/content/8/1/205. doi:10.1186/
1743-422X-8-205.
13. Fichet-Calvet E, Rogers DJ: Risk maps of Lassa fever in West Africa. PLoS
Negl Trop Dis 2009, 3(3):e388. doi:10.1371/journal.pntd.0000388.
14. Bonner PC, Schmidt WP, Belmain SR, Oshin B, Baglole D, Borchert M: Poor
housing quality increases risk of rodent infestation and Lassa fever in
refugee camps of Sierra Leone. Am J Trop Med Hyg 2007, 77(1):169–175.
15. Abdulraheem IS: Public Health importance of Lassa fever epidemiology,
clinical features and current management review of literature. Afr J Clin
Exp Microbiol 2002, 3(1):33–37.
16. Hadi CM, Goba A, Khan SH, Bangura J, Sankoh M, Koroma S, Juana B, Bah A,
Coulibaly M, Bausch DG: Ribavirin for Lassa fever postexposure
prophylaxis. Emerg Infect Dis 2010, 16(12):2009–2010. doi: 10.3201/
eid1612.100994.
17. World Health Organisation: Lassa fever in Nigeria. In Global Alert and
Response. http://www.who.int/csr/don/2012_04_04/en/.
18. Haas WH, Breuer T, Pfaff G, Schmitz H, Köhler P, Asper M, Emmerich P,
Drosten C, Gölnitz U, Fleischer K, Günther S: Imported Lassa fever in
Germany: surveillance and management of contact persons. Clin Infect
Dis 2003, 36(10):1254–1258.
19. Grove JN, Branco LM, Boisen ML, Muncy IJ, Henderson LA, Schieffellin JS,
Robinson JE, Bangura JJ, Fonnie M, Schoepp RJ, Hensley LE, Seisay A, Fair
JN, Garry RF: Capacity building permitting comprehensive monitoring of
Olowookere et al. BMC Infectious Diseases 2014, 14:344 Page 7 of 8
http://www.biomedcentral.com/1471-2334/14/344
a severe case of Lassa hemorrhagic fever in Sierra Leone with a positive
outcome: Case Report. Virol J 2011, 8:314. doi:10.1186/1743-422X-8-3.
20. Amorosa V, MacNeil A, McConnell R, Patel A, Dillon KE, Hamilton K, Erickson
BR, Campbell S, Knust B, Cannon D, Miller D, Manning C, Rollin PE, Nichol
ST: Imported Lassa Fever, Pennsylvania, USA, 2010. Emerg Infect Dis 2010,
16(10):1598–1600. http://wwwnc.cdc.gov/eid/article/16/10/10-0774_article.
doi: 10.3201/eid1610.100774.
21. Ignatyev G, Steinkasserer A, Streltsova M, Atrasheuskaya A, Agafonov A,
Lubitz W: Experimental study on the possibility of treatment of some
hemorrhagic fevers. J Biotechnol 2000, 83(1–2):67–76.
22. Colebunders R, Van Esbroeck M, Moreau M, Borchert M: Imported viral
haemorrhagic fever with a potential for person-to-person transmission:
review and recommendations for initial management of a suspected
case in Belgium. Acta Clin Belg 2002, 57(5):233–240.
23. Hugonnet S, Sax H, Pittet D: Management of viral haemorrhagic fevers in
Switzerland. Euro Surveill 2002, 7(3): http://www.cdc.gov/vhf/lassa/.
24. CDC: Lassa fever. In CDC Bulletin. 2004. http://www.cdc.gov/vhf/lassa/.
Accessed 10 September 2011.
25. Inegbenebor U, Okosun J, Inegbenebor J: Prevention of Lassa Fever in
Nigeria. Trans R Soc Trop Med Hyg 2010, 104(1):51–54. doi:10.1016/j.
trstmh.2009.07.008.
26. Ogbu O, Ajuluchukwu E, Uneke CJ: Lassa fever in West African sub-region:
an overview. J Vector Borne Dis 2007, 44:1–11.
27. McCormick JB, King IJ, Webb PA, Scribner CL, Craven RB, Johnson KM,
Elliott LH, Belmont-Williams R: Lassa Fever Effective therapy with ribavirin.
New Eng J Med 1986, 314:20–26.
doi:10.1186/1471-2334-14-344
Cite this article as: Olowookere et al.: Diagnostic proficiency and
reporting of Lassa fever by physicians in Osun State of Nigeria. BMC
Infectious Diseases 2014 14:344.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Olowookere et al. BMC Infectious Diseases 2014, 14:344 Page 8 of 8
http://www.biomedcentral.com/1471-2334/14/344
